Sign in

CIK 0001635088 · Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
operating
EIN
981173944
Phone
441-295-5950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
  1. UPLOAD Other SEC-generated Letter
  2. 425 Deal Prospectus/Communication re Business Combination
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. S-4/A Deal Registration Statement - Business Combination
  5. UPLOAD Other SEC-generated Letter
  6. 425 Deal Prospectus/Communication re Business Combination
  7. S-4/A Deal Registration Statement - Business Combination
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. 425 Deal Prospectus/Communication re Business Combination
  10. 425 Deal Prospectus/Communication re Business Combination
  11. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  12. UPLOAD Other SEC-generated Letter
  13. 425 Deal Prospectus/Communication re Business Combination
  14. 425 Deal Prospectus/Communication re Business Combination
  15. 425 Deal Prospectus/Communication re Business Combination
  16. S-4 Deal Registration Statement - Business Combination
  17. 425 Deal Prospectus/Communication re Business Combination
  18. SC 13D/A Stake Beneficial Ownership Report
  19. 4 Insider Changes in Ownership
  20. SC 13D/A Stake Beneficial Ownership Report

Page 47 of 51 · 1,008 filings